Stockreport

Exelixis Announces Third Quarter 2019 Financial Results and Provides Corporate Update

Exelixis, Inc.  (EXEL) 
Last exelixis, inc. earnings: 2/25 04:05 pm Check Earnings Report
PDF - Total Revenue of $271.7 Million, Cabozantinib Franchise Revenue of $191.8 Million -- GAAP Diluted EPS of $0.31, Non-GAAP Diluted EPS of $0.34 -- Conference Call and We [Read more]